GUCY2C: Guanylyl cyclase C
Guanylyl cyclase that catalyzes synthesis of cyclic GMP (cGMP) from GTP.
- Drugs that act on it: 4
- Approved: 2
- In phases 1 to 3: 2
- Sponsors: 3
Who is on it, and how far along
Every drug ChEMBL records acting on GUCY2C, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Antibody-drug conjugate 1
- Protein or peptide 3
Sponsors
Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.
- Bausch Health250%
- AbbVie125%
- Takeda Pharmaceuticals USA125%
| LinaclotideBoxed warning | Approved | AbbVie | Protein or peptide | Agonist | 6 |
| PlecanatideBoxed warning | Approved | Bausch Health | Protein or peptide | Agonist | 1 |
| Dolcanatide | Phase 2 | Bausch Health | Protein or peptide | Agonist | 0 |
| Indusatumab vedotin | Phase 2 | Takeda Pharmaceuticals USA | Antibody-drug conjugate | Binding agentHeat-stable enterotoxin receptor binding agent | 0 |
- Congenital diarrhea 60.74
- Meconium ileus0.72
- Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency0.68
- Diarrheal disease0.62
- Constipation disorder0.58
- Irritable bowel syndrome0.58
- Chronic constipation0.39
- Congenital sodium diarrhea0.38
- Gastroenteritis0.37
- Duodenal atresia0.33
- Familial isolated congenital asplenia0.33
- Abnormal biliary tract morphology0.33
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1795197, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-20. Gene name, function (UniProt P25092, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets